Best Agrolife Limited (BESTAGRO)
₹16.47 -1.79% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Best Agrolife's revenue was ₹396 Cr (+4.0% year on year, +154.0% on the previous quarter), and net profit ₹40.6 Cr (+103.2% year on year); the operating margin was 19.6%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹396 | +4.0% | +154.0% |
| Operating profit | ₹77.7 | +69.0% | from loss |
| Net profit | ₹40.6 | +103.2% | from loss |
| EPS (₹) | 1.15 | +105.4% | from loss |
| Operating margin | 19.6% | — | — |
BESTAGRO delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 32.46% of the BESTAGRO shares traded on NSE were taken to delivery, against the stock's own 20-session average of 47.68%. That is lower than usual for this stock. It traded 3.1 times its average daily volume.
Delivery in the last 5 sessions: 35.3% · 36.4% · 52.3% · 54.2% · 32.5%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Best Agrolife Limited announced that its wholly owned Mauritius subsidiary has incorporated a new step-down subsidiary in Brazil named Best Agrolife Do Brazil LTDA. The entity has an authorised share capital of R$ 50,000 (fifty thousand Brazilian reais) and an initial subscription of R$ 10,000, 100% held via the Mauritius unit. The subsidiary is set up for the sale, purchase, and development of agrochemicals, agricultural products, fertilizers, and intellectual property. Incorporation was completed on June 30, 2026, with disclosure delayed due to overseas consultant document receipt.
- Incorporated wholly owned step-down subsidiary Best Agrolife Do Brazil LTDA on June 8, 2026 (completed June 30, 2026)
- Authorised capital is R$ 50,000 divided into 50,000 shares of R$ 1.00 each
- Initial cash subscription is R$ 10,000, holding 100% control via Best Agrolife Global, Mauritius
- Target operations cover trading and development of agrochemicals and intellectual property in Brazil
Best Agrolife Limited has submitted its Structured Digital Database (SDD) compliance certificate under SEBI (PIT) Regulations for the quarter ended September 30, 2026. The company confirmed that 1 required event (un-audited financial results for the quarter ended June 30, 2026) was captured in the database during the quarter. No non-compliances were reported, and the database maintains audit trails capable of preserving records for 8 years. This is a standard quarterly regulatory filing with zero impact on operating financials.
- Compliance certificate submitted for the quarter ended September 30, 2026
- Exactly 1 required event was mandated and captured during the quarter
- Event captured: Un-audited financial results for the quarter ended June 30, 2026 (intimation on 23/07/2026, outcome on 30/07/2026)
- System retains audit trails internally for up to 8 years
- Zero non-compliances observed in the reported quarter
Best Agrolife Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate issued by Skyline Financial Services Pvt. Ltd. confirms that no physical share certificates were received for dematerialization during the period. The submission is purely administrative and carries no impact on operational performance or financial standing.
- Compliance certificate submitted under Regulation 74(5) of SEBI Regulations, 2018
- Pertains to the quarter ended September 30, 2026
- Registrar Skyline Financial Services confirmed zero physical share certificates received for dematerialization
- Filing dated October 07, 2026 following RTA confirmation on October 03, 2026
Best Agrolife Limited has issued a communication under Regulation 36(1)(b) of SEBI LODR providing the web-link for its FY 2025-26 Annual Report to shareholders without registered email addresses. The company confirmed that its 35th Annual General Meeting (AGM) will take place on Tuesday, September 29, 2026, at 12:30 PM IST via video conferencing. This is a standard statutory compliance filing containing procedural details for e-voting and meeting participation.
- 35th Annual General Meeting scheduled for September 29, 2026, at 12:30 PM IST via VC/OAVM
- AGM notice is dated September 1, 2026
- Dispatched web-link for the FY 2025-26 Annual Report to unregistered email shareholders per SEBI LODR Reg 36(1)(b)
- RTA for the meeting process is Skyline Financial Services Private Limited
Best Agrolife Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 pursuant to SEBI Listing Regulations. The report details standalone turnover of ₹907.27 crore and net worth of ₹387.97 crore for the standalone entity. Business segment contribution stood at 54% from insecticides, 26% herbicides, 14% fungicides, and 6% plant growth regulators. The company reported operational presence across 21 Indian states and continued global expansion efforts with registrations progressing in Mexico, Sri Lanka, Thailand, and Vietnam.
- Revenue breakdown by segment: Insecticides 54%, Herbicides 26%, Fungicides 14%, and Plant Growth Regulators & others 6%
- Standalone turnover reported at ₹907.27 crore with standalone net worth of ₹387.97 crore
- Geographic footprint spans 21 states domestically and international product registration pipeline across Mexico, Thailand, Vietnam, and Sri Lanka
- Total permanent workforce stood at 454 employees, with an annual permanent employee turnover rate of 45% in FY26
Best Agrolife Limited has issued the notice convening its 35th Annual General Meeting (AGM) scheduled for September 29, 2026. The key agenda includes adoption of FY26 financial statements and approval of a dividend of ₹0.10 (10%) per equity share of ₹1 face value. Additionally, the company seeks shareholder approval for executive remuneration exceeding standard statutory profit thresholds (including for MD Vimal Kumar exceeding ₹5 crore or 2.5% of net profits) and material related-party transactions with Kashmir Chemicals for FY27.
- 35th AGM scheduled for September 29, 2026 at 12:30 PM via Video Conferencing.
- Proposed final dividend of ₹0.10 (10%) per equity share of face value ₹1 each for FY26.
- Special resolution seeking approval for managerial remuneration exceeding the 11% net profit statutory limit under Section 197.
- Revision of remuneration terms for Whole-time Director Mr. Surendra Sai Nallamalli to ₹12.50 lakh–₹20.00 lakh per month.
- Approval sought for material related party transactions with Kashmir Chemicals for FY 2026-27.
Best Agrolife Limited has fixed September 22, 2026, as the record date to determine shareholder eligibility for the dividend for FY 2025-26. Subject to approval at the upcoming Annual General Meeting, the dividend will be paid on or after September 29, 2026. The company reported TTM revenue of ₹1,272 Cr and net profit of ₹30 Cr.
- Record date fixed as September 22, 2026 for FY26 dividend eligibility
- Dividend payment scheduled on or after September 29, 2026, subject to AGM approval
- Applies to all eligible equity shareholders as of the record date
Best Agrolife Limited has announced the outcome of its Board Meeting held on September 1, 2026. The Board approved the FY26 Annual Report and scheduled its 35th Annual General Meeting (AGM) for September 29, 2026, via video conferencing. September 22, 2026, has been fixed as both the cut-off date for remote e-voting and the record date for determining eligibility for the final dividend. Remote e-voting will take place from September 26 to September 28, 2026.
- 35th AGM scheduled to be convened on September 29, 2026, at 12:30 PM IST via VC/OAVM
- Record date for final dividend entitlement fixed as Tuesday, September 22, 2026
- Remote e-voting window opens September 26, 2026 (9:00 AM) and closes September 28, 2026 (5:00 PM)
- Board approved the Directors' Report and Annual Report for the financial year ended March 31, 2026
Best Agrolife Limited has scheduled a Non-Deal Roadshow (NDR) for August 10, 2026, in Mumbai to interact with institutional investors. This outreach occurs as the company navigates a period of earnings volatility, having reported a net loss of Rs 37 Cr in the March 2026 quarter despite a TTM revenue of Rs 1257 Cr. The company is currently pivoting toward a patented product portfolio, which now represents over 50% of its brand mix, aiming for higher EBITDA margins. No unpublished price sensitive information (UPSI) will be shared during this routine engagement.
- Non-Deal Roadshow scheduled for August 10, 2026, at ITC Maratha, Mumbai
- TTM Revenue of Rs 1257 Cr against a current Market Cap of Rs 755 Cr
- Patented products now exceed 50% of the total brand mix
- Reported a net loss of Rs 37 Cr in the most recent March 2026 quarter
Best Agrolife reported a resilient Q1 FY27 with revenue growing 4% YoY to ₹396 Cr, despite delayed monsoons and El Niño concerns. The company achieved a significant margin expansion, with Gross Margins reaching 37% and PAT more than doubling to ₹41 Cr, driven by a strategic shift toward patented products. Management has proactively provided ₹60 Cr for potential sales returns to mitigate historical volatility in the second half of the year. While early season demand was subdued, recent rainfall improvements have led to a cautiously optimistic outlook for the Rabi season.
- PAT more than doubled YoY to ₹41 Cr in Q1 FY27, up from ₹20 Cr in the same period last year.
- Patented product contribution to branded sales increased significantly to 65% from 45% YoY.
- EBITDA grew by 70% YoY with EBITDA margins reaching 20% due to favorable product mix.
- A prudent provision of ₹60 Cr (approx 20% of expected returns) was made to buffer against future sales returns.
- Gross margins expanded by 800 basis points to 37% from 29% in the previous year's quarter.
Best Agrolife Limited has released the audio recording of its Q1 FY27 earnings conference call held on July 31, 2026. This follows a volatile FY26 where the company reported TTM revenue of Rs 1,257 Cr and a thin PAT of Rs 9 Cr. The company is currently navigating a transition to a 'pull' model and focusing on its patented portfolio, which now accounts for over 50% of the brand mix. Investors should review the call for management's strategy to recover from the Rs 37 Cr net loss reported in the March 2026 quarter.
- Audio recording for the quarter ended June 30, 2026, uploaded on July 31, 2026
- Company reported TTM revenue of Rs 1,257 Cr with an operating margin of 8.0%
- Patented products now exceed 50% of the total brand mix
- Recent quarterly performance (Mar 2026) showed a net loss of Rs 37 Cr
- Promoter holding remains stable at 50.44% as of March 2026
Best Agrolife reported a strong turnaround in Q1 FY27, with PAT doubling to ₹41 crore compared to ₹20 crore in Q1 FY26. Revenue grew 4% YoY to ₹396 crore, but more significantly, it surged 154% sequentially from a weak Q4 FY26. The growth was driven by a 37% volume increase in patented products, which now comprise 64% of branded sales. EBITDA margins expanded by 800 bps to 20%, reflecting a successful shift toward high-margin proprietary formulations despite uneven monsoon rainfall.
- PAT increased 104% YoY to ₹41 crore, representing a sharp recovery from the ₹37 crore loss in Q4 FY26.
- EBITDA margins improved to 20% from 12% YoY, driven by gross margin expansion to 37%.
- Patented products' contribution to branded sales rose to 64% from 45% in the previous year.
- Volume of patented products sold increased by 37% YoY.
- Company secured multiple new registrations including 9(3) TIM for Fluxametamide and Clethodim.
Best Agrolife Limited has reported a significant update regarding its December 2024 preferential issue of convertible warrants. The company has forfeited ₹37.50 crore following the lapse of warrants held by Excello Fin Lea Limited and Nova Global Opportunities Fund due to non-payment. Consequently, the planned allocation for Capital Expenditure has been revised downward from ₹70 crore to ₹50 crore, as these funds are no longer available for utilization.
- ₹37.50 crore forfeited by the company due to the lapse of convertible warrants
- Capital Expenditure allocation reduced to ₹50 crore from the original ₹70 crore
- Non-receipt of funds from specific investors: Excello Fin Lea Limited and Nova Global Opportunities Fund
- Total initial fundraise amount via preferential issue was ₹150 crore dated 27-12-2024
- Board formally took note of the warrant lapse and forfeiture in a meeting on June 27, 2026
Best Agrolife reported a strong start to FY27 with PAT doubling to ₹41 Cr, a 104% YoY increase, despite a modest 4% revenue growth to ₹396 Cr. The performance was primarily driven by a significant expansion in EBITDA margins, which rose to 20% from 12% in the previous year, aided by a favorable product mix and price increases. Inventory levels saw a healthy reduction of 6% to ₹764 Cr, indicating better working capital management. However, the company remains under the cloud of ongoing income tax reassessments for multiple assessment years following a 2023 search operation.
- Net Profit (PAT) surged 104% YoY to ₹41 Cr in Q1 FY27 from ₹20 Cr in Q1 FY26.
- EBITDA margins expanded by 800 basis points to 20% compared to 12% in the same quarter last year.
- Gross margins improved significantly to 37% from 29% YoY, driven by patented products like Fluzam and Cubax Power Extra.
- Inventory reduced by ₹48 Cr (6%) to ₹764 Cr as of June 30, 2026.
- Revenue from operations grew 4% YoY to ₹396 Cr despite delayed monsoons affecting Kharif sowing.
Best Agrolife Limited has scheduled its earnings conference call for the quarter ended June 30, 2026 (Q1 FY27), on July 31, 2026, at 3:00 PM IST. This call follows a volatile period where the company reported a net loss of ₹37 Cr in the March 2026 quarter despite a TTM revenue of ₹1,257 Cr. Investors will be looking for updates on the company's transition to a 'pull' model and the performance of its patented portfolio, which targets 30-35% EBITDA margins. The management, including the Whole-Time Director and CFO, will discuss operational and un-audited financial performance.
- Earnings conference call for Q1 FY27 scheduled for July 31, 2026, at 3:00 PM IST
- Management participants include Mr. Surendra Sai Nallamalli (Whole-Time Director) and Mr. Vikas Jain (CFO)
- The call will address un-audited financial performance for the quarter ended June 30, 2026
- Conference call transcript to be made available on the company website within 5 working days
Financial Performance
Revenue Growth by Segment
Branded sales now constitute 65-66% of total revenue, reflecting a strategic shift toward high-value products. Overall revenue for FY25 stood at INR 1,814.31 Cr, a 3.16% decline from INR 1,873.53 Cr in FY24. Q2 FY26 revenue was INR 516.8 Cr, representing a 30.8% YoY decline from INR 746.6 Cr in Q2 FY25 due to unfavorable weather and a conscious shift to a 'pull' model.
Geographic Revenue Split
The company operates through 5,200 to 10,000+ distribution outlets across India and abroad. Specific regional percentage splits are not disclosed, but manufacturing is concentrated in Gajraula (UP), Greater Noida (UP), and Jammu (J&K).
Profitability Margins
Gross margins for H1 FY26 were reported at 36%. PAT margin for FY25 was 3.85%, down from 5.67% in FY24. Q2 FY26 PAT margin was 7.4% compared to 12.7% in Q2 FY25. The decline is attributed to increased marketing overheads for branded sales and selling high-priced inventory at losses.
EBITDA Margin
EBITDA margin for FY25 was ~11%, significantly lower than the previous expectation of 15-16% and the 12% achieved in FY24. Q2 FY26 EBITDA margin stood at 15% (INR 77.5 Cr) compared to 19.7% (INR 147.1 Cr) in Q2 FY25. The company targets a stabilized EBITDA margin of 13-14% over the medium term.
Capital Expenditure
The company is expanding technical manufacturing capacity; however, specific INR Cr values for planned capex were not disclosed. Prudent management of debt-funded capex is cited as a key rating sensitivity factor to avoid further liquidity stress.
Credit Rating & Borrowing
CRISIL downgraded the long-term rating to 'CRISIL BBB/Stable' from 'CRISIL BBB+/Stable' in August 2025. Interest coverage moderated to ~3 times in FY25 from an expected 5 times. Bank line utilization averaged 85% through May 2025.
Operational Drivers
Raw Materials
Agrochemical technicals and formulations (insecticides, pesticides, herbicides, fungicides). Specific chemical names and their % of total cost are not disclosed in the provided documents.
Import Sources
The company operates a subsidiary in Shanghai (Best Agrolife Shanghai Co. Ltd), suggesting sourcing or trade links with China. Domestic sourcing occurs near facilities in Uttar Pradesh and Jammu.
Key Suppliers
Not specifically named in the documents; however, the company maintains longstanding relationships with a diversified supplier mix to reduce concentration risk.
Capacity Expansion
Current combined technical manufacturing capacity is 7,000 TPA and formulations capacity is 30,000 TPA. Expansion is underway to meet future demand, though specific MTPA targets for the expansion phase were not disclosed.
Raw Material Costs
High-priced inventory liquidation impacted FY25 margins. The company is moving toward backward integration to support a 13% operating profitability floor and mitigate price volatility in technicals.
Manufacturing Efficiency
Capacity utilization metrics were not disclosed, but the company is focusing on improving the product mix toward higher-value patented formulations to improve absorption of fixed costs.
Logistics & Distribution
The company utilizes a network of over 5,200 distribution outlets. Distribution costs are being rationalized through geographic brand restructuring and sales team realignment.
Strategic Growth
Expected Growth Rate
13-14%
Growth Strategy
The company is transitioning to a 'pull' model to ensure sustainable demand-led growth. It is focusing on its patented portfolio, which now exceeds 50% of the brand mix. Strategy includes geographic expansion, reducing sales returns (targeted below INR 60 Cr vs INR 140 Cr previously), and launching high-margin products like Bestman and SHOT DOWN.
Products & Services
Agrochemical products including insecticides, pesticides, herbicides, fungicides, and plant nutrients sold in branded formulations.
Brand Portfolio
Best, Bestman, Fetagen, SHOT DOWN (34+ brand).
New Products/Services
Recently launched Bestman, Fetagen, and SHOT DOWN. Management plans to launch a maximum of two new products in the next financial year to maintain focus on market penetration.
Market Expansion
Focusing on exploring new geographies with better penetration and successful adoption of patented products. Branded sales are being restructured by geography to sharpen go-to-market capabilities.
Strategic Alliances
The group includes subsidiaries like BCSPL, SIPL, and Sudarshan Farm Chemicals India Pvt Ltd. No new external JV partners were named.
External Factors
Industry Trends
The industry is shifting from generic 'push' sales to specialized 'pull' demand. Global agrochemical markets are experiencing volatility, leading companies to prioritize balance sheet efficiency over headline growth.
Competitive Landscape
Faces intense competition from both domestic generic players and global agrochemical giants. Competitive advantage is sought through backward integration and niche patented formulations.
Competitive Moat
Moat is built on a growing portfolio of patented products (50% of brand mix) and a massive distribution network of 10,000+ partners. These are sustainable due to high entry barriers in R&D and long-term distributor relationships.
Macro Economic Sensitivity
Highly sensitive to agricultural cycles and monsoon patterns. Operating profitability is vulnerable to climate fluctuations.
Consumer Behavior
Farmers are increasingly responding to 'pull' marketing and specialized products like Bestman for specific issues like thrips, shifting away from generic pre-season stocking.
Geopolitical Risks
Exposure to global agrochemical troughs and peaks; operations in China (Shanghai) may be subject to trade policy shifts.
Regulatory & Governance
Industry Regulations
Operations are subject to Central Insecticides Board (CIB) registrations for new products and manufacturing standards for hazardous chemicals.
Environmental Compliance
The company operates technical and formulation plants requiring adherence to pollution control norms; however, specific ESG costs were not disclosed.
Risk Analysis
Key Uncertainties
Climate risk and monsoon dependency pose a high impact risk (30%+ revenue volatility). Working capital management is critical, with GCA at 250-300 days.
Geographic Concentration Risk
Manufacturing is concentrated in North India (UP and J&K), making it susceptible to regional regulatory or environmental disruptions.
Third Party Dependencies
High dependence on bank lines (85% utilization) for working capital requirements.
Technology Obsolescence Risk
Risk is mitigated by the shift toward patented formulations and R&D-led product launches.
Credit & Counterparty Risk
Trade receivables turnover ratio fell 38.38% to 3.53 in FY25, reflecting extended credit terms and slower collections from distributors.